William Blair Starts Korro Bio Inc. (KRRO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Korro Bio Inc. (KRRO) PT Lowered to $95 at RBC Capital
August 14, 2024 6:26 AM EDTRBC Capital analyst Luca Issi lowered the price target on Korro Bio Inc. (NASDAQ: KRRO) to $95.00 (from $105.00) while maintaining a Outperform rating.
The analyst comments "Story is on track, with lead candidate for A1AT poised to enter the clinic soon... More
